I-Ming L. Chen

903 total citations
7 papers, 32 citations indexed

About

I-Ming L. Chen is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, I-Ming L. Chen has authored 7 papers receiving a total of 32 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 2 papers in Genetics. Recurrent topics in I-Ming L. Chen's work include Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). I-Ming L. Chen is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). I-Ming L. Chen collaborates with scholars based in United States and United Kingdom. I-Ming L. Chen's co-authors include Richard C. Harvey, Albert Assad, Elizabeth M. Wagner, Deborah Hunter, Cheryl L. Willman, Elizabeth A. Raetz, Meenakshi Devidas, Charles G. Mullighan, Mignon L. Loh and Andrew J. Carroll and has published in prestigious journals such as Blood and Biopreservation and Biobanking.

In The Last Decade

I-Ming L. Chen

7 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I-Ming L. Chen United States 4 22 22 10 6 6 7 32
Alessia Campagna Italy 4 23 1.0× 22 1.0× 15 1.5× 8 1.3× 7 1.2× 11 51
Hacène Zerazhi France 4 16 0.7× 18 0.8× 7 0.7× 2 0.3× 9 1.5× 7 35
Michael Luebbert Germany 4 9 0.4× 29 1.3× 2 0.2× 7 1.2× 16 2.7× 9 33
Rogelio Paredes Aguilera Mexico 2 11 0.5× 16 0.7× 2 0.2× 4 0.7× 2 0.3× 2 16
Alexandra Lubina Solomon United Kingdom 2 6 0.3× 12 0.5× 5 0.5× 3 0.5× 4 0.7× 5 24
Ximo Duarte Portugal 2 11 0.5× 6 0.3× 8 0.8× 3 0.5× 2 0.3× 3 22
Syed Ahmer Hamid Pakistan 4 7 0.3× 5 0.2× 6 0.6× 10 1.7× 12 2.0× 9 26
H. Xiao China 3 23 1.0× 7 0.3× 2 0.2× 5 0.8× 16 2.7× 7 39
David Radvinsky United States 3 19 0.9× 2 0.1× 14 1.4× 8 1.3× 2 0.3× 3 32
Stefanie V. Junk Germany 3 10 0.5× 7 0.3× 4 0.4× 12 2.0× 1 0.2× 9 19

Countries citing papers authored by I-Ming L. Chen

Since Specialization
Citations

This map shows the geographic impact of I-Ming L. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I-Ming L. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I-Ming L. Chen more than expected).

Fields of papers citing papers by I-Ming L. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I-Ming L. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I-Ming L. Chen. The network helps show where I-Ming L. Chen may publish in the future.

Co-authorship network of co-authors of I-Ming L. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of I-Ming L. Chen. A scholar is included among the top collaborators of I-Ming L. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I-Ming L. Chen. I-Ming L. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
2.
3.
Pogosova‐Agadjanyan, Era L., Anna Moseley, Megan Othus, et al.. (2017). Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report. Biopreservation and Biobanking. 16(1). 42–52. 6 indexed citations
4.
Schwab, Claire, Amir Enshaei, Kathryn G. Roberts, et al.. (2016). The Frequency and Outcome of Ph-like ALL Associated Abnormalities in Childhood Acute Lymphoblastic Leukaemia Treated on MRC UKALL2003. Blood. 128(22). 2914–2914. 5 indexed citations
5.
Tasian, Sarah K., Yong Li, Feng Shen, et al.. (2015). Potent Efficacy of Combined PI3K/mTOR and JAK or SRC/ABL Inhibition in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia. Blood. 126(23). 798–798. 2 indexed citations
6.
Urtishak, Karen, David T. Teachey, Jeffrey S. Barrett, et al.. (2013). PI3K/AKT/mTOR Signaling Is a Significant Druggable Pathway In Infant Acute Lymphoblastic Leukemia (ALL). Blood. 122(21). 1669–1669. 2 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessia Campagna Breakdown of academic impact, for papers by Hacène Zerazhi Breakdown of academic impact, for papers by Michael Luebbert Breakdown of academic impact, for papers by Rogelio Paredes Aguilera Breakdown of academic impact, for papers by Alexandra Lubina Solomon Breakdown of academic impact, for papers by Ximo Duarte Breakdown of academic impact, for papers by Syed Ahmer Hamid Breakdown of academic impact, for papers by H. Xiao Breakdown of academic impact, for papers by David Radvinsky Breakdown of academic impact, for papers by Stefanie V. Junk
Rankless by CCL
2026